1027508-87-7

Basic information

• Product Name: 4-[4-(tert-Butyl-dimethyl-silanyloxy)-phenyl]-1-{(R)-3-[4-(tert-butyl-dimethyl-silanyloxy)-phenyl]-3-hydroxy-cyclohexylmethyl}-piperidin-4-ol
• Synonyms: 4-[4-(tert-Butyl-dimethyl-silanyloxy)-phenyl]-1-{(R)-3-[4-(tert-butyl-dimethyl-silanyloxy)-phenyl]-3-hydroxy-cyclohexylmethyl}-piperidin-4-ol
• CAS NO: 1027508-87-7
• Molecular Weight: 626.04
• Mol File: 1027508-87-7.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: 4-[4-(tert-Butyl-dimethyl-silanyloxy)-phenyl]-1-{(R)-3-[4-(tert-butyl-dimethyl-silanyloxy)-phenyl]-3-hydroxy-cyclohexylmethyl}-piperidin-4-ol(CAS DataBase Reference)
• NIST Chemistry Reference: 4-[4-(tert-Butyl-dimethyl-silanyloxy)-phenyl]-1-{(R)-3-[4-(tert-butyl-dimethyl-silanyloxy)-phenyl]-3-hydroxy-cyclohexylmethyl}-piperidin-4-ol(1027508-87-7)
• EPA Substance Registry System: 4-[4-(tert-Butyl-dimethyl-silanyloxy)-phenyl]-1-{(R)-3-[4-(tert-butyl-dimethyl-silanyloxy)-phenyl]-3-hydroxy-cyclohexylmethyl}-piperidin-4-ol(1027508-87-7)

Safety Data

• Hazardous Substances Data: 1027508-87-7(Hazardous Substances Data)

Upstream product

• 67963-68-2 t-butyldimethylsilyl-4-bromophenol 
• 171522-33-1 (R)-1-<(3-oxocyclohexyl)methyl>piperidin-4-one 
• 1025980-56-6 (1,4-Dioxa-8-aza-spiro[4.5]dec-8-yl)-(R)-1,4-dioxa-spiro[4.5]dec-7-yl-methanone 
• 171522-32-0 (R)-3-(1,4-dioxa-8-azaspiro<4.5>dec-8-ylcarbonyl)cyclohexanone 
• 1026598-15-1 8-[(R)-1-(1,4-Dioxa-spiro[4.5]dec-7-yl)methyl]-1,4-dioxa-8-aza-spiro[4.5]decane 
• 177-11-7 4,4-ethylenedioxy-piperidine 

Downstream Products

• 1027409-06-8 4-[4-(tert-Butyl-dimethyl-silanyloxy)-phenyl]-1-{(R)-3-[4-(tert-butyl-dimethyl-silanyloxy)-phenyl]-cyclohex-3-enylmethyl}-1,2,3,6-tetrahydro-pyridine 

Relevant articles and documents

Identification, characterization and pharmacological profile of three metabolites of (R)-(+)-1,2,3,6-tetrahydro-4-phenyl-1-[(3-phenylcyclohexen-1- yl)methyl]pyridine (CI-1007), a dopamine autoreceptor agonist and potential antipsychotic agent

Liquid chromatographic-mass spectrometric (LC-MS) analysis of plasma taken from cynomolgus monkeys dosed orally with (R)-(+)-1,2,3,6-tetrahydro-4- phenyl-1-[(3-phenylcyclohexen-1-yl)methyl]pyridine (1), a dopamine (DA) autoreceptor agonist and potential a